A novel approach to support implementation of biosimilars within a UK tertiary hospital.

Katherine SaxbySonali SanghviPritesh N BodaliaRobin E FernerMaria LeandroRobert UrquhartReecha Sofat

Published in: British journal of clinical pharmacology (2019)

We have set up a system within a busy NHS clinical practice to successfully switch patients to biosimilars, and established a mechanism to guide decisions on continuing with or reverting back to the originator. Such a system could be of use more broadly within the NHS and other health care systems.

Keyphrases

healthcare
end stage renal disease
clinical practice
patient safety
ejection fraction
newly diagnosed
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
quality improvement